Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 33 P11 | DOI: 10.1530/endoabs.33.P11

BSPED2013 Poster Presentations (1) (89 abstracts)

Succesfully modified intermittent i.v. calcium treatment in a patient with hereditary vitamin D resistant rickets with alopecia: presence of nonsense mutation in ligand binding domain of vitamin D receptor

Betul Ersoy 1 , Seniha Kiremitci 1 & Sachiko Kitanaka 2


1Celal Bayar University, School of Medicine, Manisa, Turkey; 2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.


Hereditary vitamin D-resistant rickets (HVDRR) is a rare recessive genetic disorder caused by mutations in the VDR that result in end organ resistance to 1,25-(OH)2D3 action. Here, we describe a patient with HVDDR with severe alopecia and rickets. Patient was 3 years old male presenting with gait disorder. He had hypocalcemia (8 mg/dl), secondary hyperparathyroidism (1232 pg/ml), and elevated serum alkaline phosphatase (661 U/l) and 1,25-dihydroxyvitamin D3 (>250 pg/ml). DNA sequence analyses of the vitamin D receptor (VDR) gene of ligand binding domain (LBD) showed that the patient had homozygous mutation for Q152X at exon five. This mutation was a C to T transition resulting in a premature stop at codon 152. Although his parents were non-consanguineous, both of his parents were found to be heterozygous for the mutation. The patient was initially treated with calcitriol (80 ng/kg per day) and high dose oral calcium (150 mg/kg per day) for 1 year. At the end of the first year, intermittent i.v. calcium therapy (5 days/month) was started, because of insufficient clinical and radiological improvement. After 2 years from intermittent i.v. calcium therapy, there was a clear clinical improvement based on clinical and X-ray findings as well as permenant improvement in biochemical findings. However, alopecia in our patient remained unchanged, despite treatment and improvement of rickets. We report the case of HVDRR with a mutation in the LBD and severe alopecia that was successfully treated with intermittent (5 days/month) i.v. calcium treatment.

Volume 33

41st Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.